Nurses' guide to understanding and implementing the National Comprehensive Cancer Network guidelines for myeloid...

Area of Science:

• Oncology Nursing
• Clinical Practice Guidelines
• Evidence-Based Practice

Background:

• Chemotherapy-induced neutropenia is a significant adverse event.
• Neutropenia can lead to severe infections, hospitalization, and reduced treatment efficacy.
• Adherence to clinical guidelines is crucial for managing chemotherapy side effects.

Purpose of the Study:

• To evaluate the applicability of the 2006 National Comprehensive Cancer Network (NCCN) guidelines.
• To assess the use of myeloid growth factors in adult cancer patients receiving chemotherapy.
• To determine guideline relevance for solid tumors and nonmyeloid malignancies.

Main Methods:

• Systematic review of published literature.
• Inclusion of original research, review articles, and conference presentations.
• Analysis of data sources to determine guideline applicability.

Main Results:

• Chemotherapy-induced neutropenia is a common and serious complication.
• Neutropenia can result in life-threatening infections and prolonged hospital stays.
• Adverse effects impact patient quality of life and treatment outcomes.

Conclusions:

• Nurses play a key role in identifying patients at risk for neutropenia.
• Implementing a risk assessment plan is essential before chemotherapy initiation.
• Adopting NCCN guidelines standardizes care and optimizes patient management.